Chemoinformaics analysis of 8-Hydroxy-2-octanone
| Molecular Weight | 144.214 | nRot | 6 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 17 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -2.715 | nHRing | 0 |
| Solubility: LogP | 2.906 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.6327 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.625 |
| Synth | 3.859 |
| Natural Product Likeliness | 0.947 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.007 |
| HIA | 0.014 |
| CACO-2 | -4.807 |
| MDCK | 0.000021 |
| BBB | 0.964 |
| PPB | 0.496637 |
| VDSS | 6.632 |
| FU | 0.347384 |
| CYP1A2-inh | 0.109 |
| CYP1A2-sub | 0.182 |
| CYP2c19-inh | 0.076 |
| CYP2c19-sub | 0.849 |
| CYP2c9-inh | 0.085 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.978 |
| CYP2d6-sub | 0.784 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.743 |
| CL | 10.689 |
| T12 | 0.313 |
| hERG | 0.925 |
| Ames | 0.044 |
| ROA | 0.426 |
| SkinSen | 0.447 |
| Carcinogencity | 0.135 |
| EI | 0.011 |
| Respiratory | 0.521 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.945148 |